#HappyNewYear
go.bsky.app/6hgNDdr
#HappyNewYear
go.bsky.app/6hgNDdr
- needs more investigation and great science.
#Telomeres
#CureIPF
🧪
🧬
This paper shows that mouse telomeres do not shorten with age. Should we revisit the paradigm?
Kudos Drs Smoom, Tzfati & team!!!
#ScienceMattets
academic.oup.com/nar/article/...
- needs more investigation and great science.
#Telomeres
#CureIPF
🧪
🧬
Emerging evidence of their role pulmonary fibrosis.
#CureIPF
#Telomeres
@elife.bsky.social
@rcsi.bsky.social
@kaminskimed.bsky.social
Emerging evidence of their role pulmonary fibrosis.
#CureIPF
#Telomeres
@elife.bsky.social
@rcsi.bsky.social
@kaminskimed.bsky.social
Just out in ERJ and led by Dr. Na'ama Avitzur
A 🧵👇
(key take-away 👉 sex matters to patients with PF and their disease impacts this)
#OpenAccess #CurePF #CureIPF
publications.ersnet.org/content/erj/...
Just out in ERJ and led by Dr. Na'ama Avitzur
A 🧵👇
(key take-away 👉 sex matters to patients with PF and their disease impacts this)
#OpenAccess #CurePF #CureIPF
publications.ersnet.org/content/erj/...
@nebanovich.bsky.social @kaminskimed.bsky.social
www.biorxiv.org/content/10.1...
With patients like David Crosby we aim to find treatments for pulmonary fibrosis and cystic fibrosis.
🧪
#CureIPF
#iPSC
#CF
Supporting work by
@erc.europa.eu
@researchireland.bsky.social
HRB
Learn more from Professor Killian Hurley and patient advocate David Crosby in the video below ⬇️
youtu.be/cg3fKicccTI
With patients like David Crosby we aim to find treatments for pulmonary fibrosis and cystic fibrosis.
🧪
#CureIPF
#iPSC
#CF
Supporting work by
@erc.europa.eu
@researchireland.bsky.social
HRB
Thanks for putting this together Naftali and giving leadership in the field.
#CureIPF
#CureFibrosis
#IPF2025
#HappyNewYear
go.bsky.app/6hgNDdr
Thanks for putting this together Naftali and giving leadership in the field.
#CureIPF
#CureFibrosis
#IPF2025
#CureIPF
#CleanAir
www.atsjournals.org/doi/10.1513/...
#CureIPF
#CleanAir
www.atsjournals.org/doi/10.1513/...
@atscommunity.bsky.social
@atsearlycareer.bsky.social
@ats-rcmb.bsky.social
@atscommunity.bsky.social
@atsearlycareer.bsky.social
@ats-rcmb.bsky.social
#AcademicBliss
Grateful to all our amazing partners and collaborators!!!
#TeamsMatter
#CureIPF
#AcademicBliss
Grateful to all our amazing partners and collaborators!!!
#TeamsMatter
#CureIPF
#CurePF4All
#CurePF4All
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
#CurePF #CureIPF #ILD
go.bsky.app/8u4KcNo
RCSI showing data from our familial pulmonary fibrosis clinic.
- 1 in 5 patients have a family memeber with lung fibrosis.
- 1 in 5 of these patients have a single suspected gene.
#CureIPF
@europeanrespsoc.bsky.social
RCSI showing data from our familial pulmonary fibrosis clinic.
- 1 in 5 patients have a family memeber with lung fibrosis.
- 1 in 5 of these patients have a single suspected gene.
#CureIPF
@europeanrespsoc.bsky.social
@ipfdoc.bsky.social @kaminskimed.bsky.social
#CurePF #CureIPF @ats-clinicalprobs.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social
pmc.ncbi.nlm.nih.gov/articles/pmi...
@ipfdoc.bsky.social @kaminskimed.bsky.social
#CurePF #CureIPF @ats-clinicalprobs.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social
pmc.ncbi.nlm.nih.gov/articles/pmi...
Kudos Drs Yadav, Bhattacharya & team
www.jci.org/articles/vie...
@jclinical-invest.bsky.social #CureIPF
Kudos Drs Yadav, Bhattacharya & team
www.jci.org/articles/vie...
@jclinical-invest.bsky.social #CureIPF
Prof Silke Meiners at our Living Lung talk today.
Her talk on the immunoprotesome related to infection inflammation and lung diseases 🫁 such as #COPD and #IPF
Thank you Silke 🙏
#SciSky
#MedSky
#CureIPF
#HealthResearchMatters
@ilfa-ireland.bsky.social
Prof Silke Meiners at our Living Lung talk today.
Her talk on the immunoprotesome related to infection inflammation and lung diseases 🫁 such as #COPD and #IPF
Thank you Silke 🙏
#SciSky
#MedSky
#CureIPF
#HealthResearchMatters
@ilfa-ireland.bsky.social
Nintedanib for SSc-ILD at Scleroderma centres in the US.
Not one 🫁 MD on this paper 👀
Are Rheumatologists treating/managing ILD at your centres?
@jskim8223.bsky.social @ipfdoc.bsky.social @tkulkarni.bsky.social @istamina.bsky.social
Nintedanib for SSc-ILD at Scleroderma centres in the US.
Not one 🫁 MD on this paper 👀
Are Rheumatologists treating/managing ILD at your centres?
@jskim8223.bsky.social @ipfdoc.bsky.social @tkulkarni.bsky.social @istamina.bsky.social
#זScienceMatters
#CureIPF
www.jci.org/articles/vie...
#זScienceMatters
#CureIPF
www.jci.org/articles/vie...
Unsurprisingly, answer is YES & NO.
My suggestion - use statins as statins, antifibrotics as antifibrotics.
And keep developing/testing drugs designed to reverse fibrosis.
#CureIPF
www.tandfonline.com/doi/full/10....
www.nature.com/articles/s41...
Unsurprisingly, answer is YES & NO.
My suggestion - use statins as statins, antifibrotics as antifibrotics.
And keep developing/testing drugs designed to reverse fibrosis.
#CureIPF
www.tandfonline.com/doi/full/10....
www.nature.com/articles/s41...
#CureIPF
#CureIPF
Using snRNAseq we identify a previously undiscovered population of alveolar epithelial cells in IPF - Alveolar Intermediate (ATi) cells - they share features of ATI, ATII and Aberrant Basaloid cells but also have their own distinct features.
#ATi
#CureIPF
www.biorxiv.org/content/10.1...
Using snRNAseq we identify a previously undiscovered population of alveolar epithelial cells in IPF - Alveolar Intermediate (ATi) cells - they share features of ATI, ATII and Aberrant Basaloid cells but also have their own distinct features.
#ATi
#CureIPF
www.biorxiv.org/content/10.1...